The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has been the lead Federal agency responsible for scientific research on alcohol and its effects for 40 years. During that time, NIAAA has conducted and funded groundbreaking research, distilled and disseminated those research findings to a broad audience, and ultimately improved public health. Among NIAAA's many significant contributions are the National Epidemiologic Survey on Alcohol and Related Conditions, the largest survey ever conducted on alcohol and associated psychiatric and medical conditions; investment in research to identify the genes underlying vulnerability to alcoholism; creation of the Collaborative Studies on Genetics of Alcoholism, a study of the genetics of alcoholism in a human population; leadership in exploring the effects of alcohol on fetal development and on a variety of diseases and organ systems; fostering alcoholism treatment, including supporting a medications development program that has funded more than 30 Phase 2 trials and 15 human laboratory studies; international collaborations and work across the National Institutes of Health; influential research on preventing alcohol problems through community programs as well as policy changes; and the translation of research findings to everyday practice, including the production of awardwinning clinician training materials. KEY WORDS: Alcoholism; alcohol and other drug use, abuse, and dependence; 
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has been the lead Federal agency responsible for scientific research on alcohol and its effects for 40 years. During that time, NIAAA has conducted and funded groundbreaking research, distilled and disseminated those research findings to a broad audience, and ultimately improved public health. Among NIAAA's many significant contributions are the National Epidemiologic Survey on Alcohol and Related Conditions, the largest survey ever conducted on alcohol and associated psychiatric and medical conditions; investment in research to identify the genes underlying vulnerability to alcoholism; creation of the Collaborative Studies on Genetics of Alcoholism, a study of the genetics of alcoholism in a human population; leadership in exploring the effects of alcohol on fetal development and on a variety of diseases and organ systems; fostering alcoholism treatment, including supporting a medications development program that has funded more than 30 Phase 2 trials and 15 human laboratory studies; international collaborations and work across the National Institutes of Health; influential research on preventing alcohol problems through community programs as well as policy changes; and the translation of research findings to everyday practice, including the production of awardwinning clinician training materials. With the passage of that law, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) became the lead Federal agency to address the problems associated with alcohol abuse and alcoholism. Over time, NIAAA has continued to evolve. Today's research portfolio casts a net over a wide range of study-from epigenetics and neuro imaging to health disparities and per sonalized medicine. NIAAA continues to spark innovative approaches to research problems, to foster cooperation and collaboration with other agencies and programs, and to advance our understanding of alcohol and its effects.
For example, NIAAA took the lead in supporting research to explore alcohol's effects on fetal development in the 1970s, when many scientists and physicians doubted the existence of fetal alcohol spectrum disorder (FASD) . NIAAA held the first inter national research conference on FASD in 1977 and issued the first government health advisory on FASD on June 1, 1977. (For an indepth look at NIAAA's role in FASD research, see the article on p. 118 of this issue.)
In addition to FASD research, NIAAA has supported important work on other medical consequences as well as the potential benefits of alcohol use. Such research has provided a better understanding of alcohol's role in diseases such as cancer, diabetes, dementia, and obesity; how alcohol affects the liver, brain, and immune system; and cooccurring alcohol and mental health disorders. (For more information on the medical conse quences and potential benefits of alcohol, see the section beginning on p. 76 of this issue.) Alcoholism has long been recog nized to run in families. NIAAA's efforts to explore the genetic compo nent of alcoholism led to the estab lishment of the Collaborative Studies on Genetics of Alcoholism (COGA) to identify genes associated with vulnerability for alcohol dependence. This study has facilitated gene discovery, contributed to the development of medications for alcoholism, helped to identify those at risk for alcohol problems, and furthered research on the relationships between alcoholism and other disorders.
NIAAA's outreach has extended well beyond the research lab. NIAAA has collaborated with other Federal agencies and published numerous books, pamphlets, and brochures to bring awareness of alcoholrelated issues to a variety of audiences. NIAAA's initiative on understanding and pre venting underage drinking led to collaboration with the U.S. Surgeon General and the production of the Surgeon General's Report, A Call to Action To Prevent and Reduce Underage Drinking. This valuable report, pub lished in 2007, turned the Nation's attention to the problem of underage drinking and highlighted promising strategies for prevention and intervention.
NIAAA's leadership in both the research and public health communities has ensured that what is learned through research is put into practice. Perspectives on alcoholism were shifting, and many Americans, within and outside the scientific community, were beginning to see alcoholism as a problem that would yield to scientific solutions. By the 1950s, public health organizations such as the American Medical Association and the World Health Organization were addressing alco holism in health care settings. By the 1960s, the American Psychiatric Association had declared alcoholism an illness. States began to develop treatment and support programs for alcoholics. However, these pro grams were often underfunded and underdeveloped. In order to make an impact, the Nation would have to address alcoholism on a Federal level, devoting national resources to the problem.
As perceptions on alcoholism changed, the Federal Government began to treat alcoholism as a pub lic health problem. In the 1960s, the National Institute of Mental Health (NIMH) in the U.S. Public Health Service began a very small program of grants in the alcohol area. This led to the establishment in 1965 of the Center for the Prevention and Control of Alcohol Problems as a component of NIMH. However, under NIMH, the Center had limited authority and a limited budget. More resources were des perately needed for research. In a 1967 report, the Cooperative Commission on the Study of Alcoholism stated that "additional information about the nature and causes of problem drinking is urgently needed."
Researchers and policymakers felt that to comprehensively address the problem, a highly placed-and therefore highly visible-Federal treatment of alcoholism. Forty years ago, the diagnosis of "alcoholic" car ried a negative connotation. NIAAA and grassroots organizations such as Alcoholics Anonymous helped to change that perception, moving the public's view of alcoholism as a "moral failing" toward one that views alco holism as a disease that, like diabetes or heart disease, can be treated. 
Impact
The strengths of the NESARC are reflected in the more than 300 peer reviewed journal articles based on or citing the dataset, including almost 80 in the past year. The longitudinal design of the NESARC has permitted the first nationally representative estimates of the course of alcohol use and other mental disorders in the United States. One of the major research reports to come out of the NESARC estimated the 1year incidence rates for alcohol and drug use disorders, mood disorders (including major depressive and bipolar I and II disorders), and anxiety disorders (including panic disorder, specific and social phobia, and generalized anxiety disorder) and importantly showed that although mood and anxiety disorders were independently associated with the incidence of substance use disorders, the converse was not true ). What made this study unique was its ability to control for multiple comorbidities in assessing the prospec tive effect of one disorder on the odds of developing a second disorder, thus helping to identify common underly ing (shared) versus disorderspecific risk factors for disease. The NESARC also has been used extensively to study comorbidity in a crosssectional per spective (e.g., Grant et al. 2004a Grant et al. , b, c, 2005 Hasin et al. 2007; Stinson et al. 2005) .
Studies of the course of alcohol dependence based on the NESARC have led researchers to question the perception of alcoholism as a chronic and remitting disorder for which the only solution is lifelong abstinence. Retrospective data from the Wave 1 NESARC revealed that half of all adults previously classified with alcohol dependence were in full remission in the year preceding the Wave 1 NESARC and that nearly onequarter had returned to lowrisk drinking . However, data from Wave 2 showed that relapse rates among remitted alcoholics were higher among drinkers than abstainers, except among remitted alcoholics 18-24 years of age at Wave 1. For this latter group, relapse rates were high irrespec tive of type of remission, highlighting a particularly vulnerable group in need of new approaches for maintaining sobriety or abstinence (Dawson et al. 2007) . Wave 2 NESARC data also revealed associations of transitions in and out of alcohol use disorders with changes in risk drinking and health related quality of life (Dawson et al. 2008 (Dawson et al. , 2009 .
NESARC alcohol consumption data have played a key role in the Global Burden of Disease Project, which used NESARC measures of the preva lence of drinking, average volume of consumption, and frequency of heavy episodic drinking to develop alcohol attributable fractions of disease for the United States (Rehm et al., in press ). These fractions, which indicate the proportion of the prevalence of a specified disease that would not exist in the absence of alcohol consump tion (i.e., the proportion that can be attributed to the effects of alcohol), are an important tool for assessing pub lic health priorities in the United States and for international comparisons.
Future Directions
The unprecedented scope of information yielded by NESARC has been put to many additional uses, including assess ment of the underlying factor structures and dimensionality of substance use and mental disorders. NESARC con sumption data have been used to both inform and monitor progress toward achieving lowrisk drinking guidelines. In addition, NESARC symptom item indicators have formed the empirical basis against which proposed revisions of the DSM have been evaluated. These diverse applications reflect the wide reaching impact the NESARC has had and will continue to have in the fields of alcohol research and psychi atric epidemiology.
Analyses of survey data help define populations at risk for alcohol abuse and alcoholism. Research on the genetic component of alcoholism risk has helped to further explain why some individuals are more likely than others to experience alcoholrelated problems. As described below, NIAAA adopted this research project as one of its primary missions for improving public health and was one of the first Institutes to take the lead in understanding the genetics underlying a complex disease.
Genetics of Alcoholism
A genetic predisposition for alcoholism has long been suspected because of the observation that alcoholism tends to "run in families." However, this in and of itself is not proof of a genetic vulner ability because a shared environment also could explain the pattern. It was not until the 1970s that this notion was scientifically tested in a systematic fashion. Adoption studies were the first to con clusively point to a sound involvement of genetic factors as playing a role in predisposition to alcoholism. Goodwin and colleagues (1973) studied the drink ing history of 55 adoptedout sons of alcoholics and 78 adoptedout sons of nonalcoholics. All of the sons were adopted as infants, within the first 6 weeks of life. Importantly, the sons of alcoholics had no knowledge that their biological parents suffered from alcoholism. The results were striking. Biological sons of alcoholics who had been adopted by nonrelated foster fam ilies were four times as likely to become alcoholics compared with biological sons of nonalcoholics. Subsequently, similar lines of research in twin and family studies have convincingly demonstrated that genetic factors account for between 50 and 60 percent of the vulnerability to alcoholism.
Genetic Mapping in Animal Models
These results spurred intense research that began in the last several decades of the 20th century to find the genes that underlie vulnerability to alcoholism. NIAAA's critical investment in COGA, which began in 1989, helped further the understanding of the genetics of alcoholism in a human population (see below). However, because of the complex nature of alcoholism and the substantial genetic heterogeneity known to underlie it in human populations, alternative and complementary approaches were sought to further advance the field. Genetic animal models, and in particular mouse genetic models, offer an alternative and complementary approach for iden tifying the genes underlying alcoholism. The principal reasons are that they provide a means of reducing genetic heterogeneity and allow for a tighter control of environmental variation.
In the late 1980s, genetic mapping in mouse models of alcoholism became a reality because of technological breakthroughs. A method called quantitative trait loci (QTL) 1 mapping began to be used in a host of mouse models to determine the chromosomal regions containing a genetic variant underlying alcoholrelated behaviors ranging from voluntary consumption to withdrawal severity. QTL mapping involves identifying (i.e., genotyping) DNA markers distributed across the entire mouse genome in different mouse strains and correlating DNA marker genotypes with a specific phenotype or trait (e.g., alcohol consumption). The question is then asked: Do mice of one genotype score differently on the trait than mice of other genotypes? If the answer is yes, and the difference is statistically sig nificant, then a QTL exists in the 1 For a definiton of this and other technical terms, see the Glossary, pp 161-164. chromosomal region defined by the DNA markers. Importantly, the homologous region of the human genome is usually known, making it ideal for translational science. NIAAA saw this as a golden opportunity and made significant investments in QTL mapping efforts in animal models of alcoholism.
By 1991, QTL mapping in mouse models for alcoholism had provisionally mapped a number of chromosomal regions containing a gene or genes associated with alcohol phenotypes. Further research in the ensuing decade resulted in the definitive mapping of several of these QTL. Highresolu tion mapping efforts began in the late 1990s, using animals with identical genetic backgrounds that differ only in a relatively small seg ment of DNA (i.e., intervalspecific congenic strains) to narrow relatively large QTL intervals to regions of less than 1 centiMorgan (cM) containing only a few genes. This was a signifi cant advance for the field because the prospect of cloning a gene based on its position (i.e., positional cloning) was now in sight. In the early 2000s, researchers identified the first bona fide quantitative trait gene (QTG). This QTG was localized to mouse chromosome 4 and was found to con tribute to genetic variability in alco hol withdrawal severity. This gene, named Mpdz, encodes the multiple PDZ domain protein (MPDZ) and had not been previously known to influence an alcohol phenotype, highlighting the sheer power of the QTL approach for identifying novel genes for a complex trait.
Advances in QTL mapping contin ued into the latter half of the 2000s with the identification of another potential QTG for an alcohol pheno type on mouse chromosome 1. QTL mapping studies in rat models of alcoholism also yielded promising candidate genes for alcohol consump tion, including neuropeptide Y, αsynuclein, and the corticotrophin releasing factor receptor. At this time, new approaches for identifying candi date genes underlying QTLs also were developed. This was spawned by advances in microarray gene expres sion technology, which enabled inves tigators to examine changes in gene expression on a genomewide scale. Using gene expression as a quantita tive trait resulted in the identification of gene networks that underlie vul nerability to alcoholism, the socalled expression QTL (eQTL) approach.
The Collaborative Studies on Genetics of Alcoholism
Complementing NIAAA's research investment in genetic mapping in ani mal models, the Institute also has been on the forefront of research to identify genes associated with vulnerability for alcohol dependence in humans. Whereas earlier research using twin, family, and adoption studies pointed to a strong genetic component for alco holism (Hesselbrock 1995) , it also showed that the development of alcohol related disorders varies widely and depends on a number of factors, from cooccurring medical and psychiatric disorders to social influences (Begleiter et al. 1995) . Recognizing the need to tease apart these genetic and environ mental factors, COGA investigators conceived a largescale multidisci plinary research program to develop resources both to define the spectrum of alcohol use disorders and to provide a welldefined study population that could be studied over time with new and emerging technologies.
The COGA project was, and still is, a truly unique research endeavor and even at its conception was inno vative in the field of the genetics of complex diseases. (The Human Genome Project was started a few years after COGA had begun.) One of COGA's major strengths lies in the rich sample of families with multiple alcoholdependent members, where the initial participant and at least two firstdegree relatives met stringent diagnostic criteria for alcoholism based on several diagnostic instru ments. In addition, over the 20 years that COGA has been funded it has produced some very valuable resources that have made the project κ itself successful and contributed to the advancement of science in general.
COGA organizers developed a robust sample from across the coun try through six core data collection sites. (As of 2010, there are 10 research sites where collection, analysis, and storage take place; see textbox.) Systematic recruitment of people receiving treatment identified indi viduals who met the stringent criteria of alcohol dependence, as described in the DSM-III-R (American Psychiatric Association 1987), and alcoholism, as described by Feighner and colleagues (1972) . For the genetic studies, investigators initially focused on the families with a high prevalence of alcohol abuse and alcoholism. A second group of families was sampled from each com munity to act as a comparison group (Edenberg 2002) . The study has grown to include more than 15,000 people from 1,900 families.
During the initial recruitment, researchers realized the importance of documenting the current status of a patient's alcohol abuse and their fami ly pedigree, as well as the conditions that presaged that condition. To sys tematically gather this information, the COGA scientists developed the SemiStructured Assessment for Genetics of Alcoholism (SSAGA), a tool for assessing and selecting indi viduals (Bucholz et al. 1994) ; this polydiagnostic instrument can make diagnoses using DSM-III-R, DSM-IV (American Psychiatric Association 1987, 1994), Feighner's (1972) , and ICD-10 (World Health Organization [WHO] 1992) criteria. SSAGA, a directinterview approach, enabled researchers to obtain both clinical detail and psychiatric histories of patients and family members. SSAGA has been translated into nine languages and now is widely used throughout the world, making com parisons across studies from different groups possible. Once identified using SSAGA, COGA family members were further characterized with exten sive neurophysiological, behavioral, and psychiatric assessments. Blood and cell samples also were collected for genetic analysis. Because of COGA, more than 11,000 DNA and cell lines are now available to researchers.
Researchers designed COGA to be reproducible and flexible in structure so that it could be quickly adapted to incorporate new findings and accom modate new approaches as the study progresses. The validity and effective ness of this approach has been borne out by many smaller studies in coun tries around the world that have repli cated and confirmed COGA's results.
COGA Sites
• Howard University 
Results
COGA's early strategy of using densely affected families has facilitated gene discovery and has provided a clearer picture of the genetics underlying alco holism. A successful approach used by COGA has been to use quantitative neurophysiological traits (brain oscilla tions) to identify susceptibility genes that may be difficult to detect with clinical diagnosis alone. In the mid 1990s, researchers published the first reports of chromosomal regions linked to a variety of alcoholrelated traits (i.e., phenotypes) in the COGA sam ple. Candidate genes within the critical linked chromosomal regions were pri oritized to determine which genes con tained variation that could contribute to the phenotypes under study. Genes encoding both specific receptor molecules for the neurotransmitter γaminobutyric acid (GABA) and alcohol metabolizing enzymes floated to the top of the list for associations with alcoholrelated phenotypes. Other less obvious genes also were discovered, such as a gene for a receptor for acetyl choline (CHRM2), a glutamate recep tor gene (GRM8), and genes encoding the protein αsynuclein and the tran scription factor, nuclear factor B. Recent studies using a DNA sequence variation occurring when a single DNA subunit (i.e., nucleotide) in the genome differs between individuals (i.e., single nucleotide polymorphisms) and approaches using a set of DNA varia tions inherited together (i.e., haplotyp ing) have further refined efforts to identify and locate genes in the sample population of alcoholdependent patients. COGA researchers also have confirmed alcohol genetic spectrum conditions, including drug dependence and some forms of anxiety and mood disorders. An important finding has been the identification of conduct disorder as a precursor to alcohol prob lems, related through a GABA A receptor gene (Dick et al. 2006 ). Most recently, COGA has implemented a genome wide association study on a case-control sample derived from COGA. To date, the list of genes associated with alcoholism in the COGA sample has grown to more than 20, highlighting a tremen dous payoff from NIAAA's investment in this project.
Future Directions
Going forward, COGA scientists have launched a prospective longitudinal study of highrisk youth ages 12-21 from families with a history of alcohol abuse as well as from comparison fami lies. This ongoing study, with fol lowups every 2 years, is designed to provide more detailed information on the interaction of genes and the environment. The data and samples accumulated by COGA may allow researchers to identify the mechanisms that underlie the onset of alcohol use disorders and to understand how these mechanisms influence risk. Scientists continue to identify and confirm other genes and gene vari ants that affect the risk for alcoholism and related phenotypes and to char acterize the expression of those genes at the molecular and cellular level. Researchers also are testing the role of changes not caused by changes in DNA (i.e., epigenetic modifications) that might alter gene expression and affect the longterm alcoholism risk for study participants and their off spring.
Ultimately, the findings from COGA will help scientists to develop new approaches for preventing and treating alcohol use disorders, identi fying the precursors for risk of alco hol problems, developing effective measures to prevent early onset of alcohol abuse, and understanding how alcohol abuse and alcoholism are related to other comorbid disorders, such as substance abuse, anxiety, mood, and spectrum disorders. (For more information on studies of the genetics of alcoholism, see the article on p. 64 of this issue.)
Advances in Medications Development
Over the past 40 years, researchers have made significant advances in develop ing medications to treat patients with alcohol use disorders. In 1992, Volpicelli and colleagues (1992) and O'Malley and colleagues (1992) reported naltrex one to be effective in reducing drinking in alcoholdependent patients. These two NIAAAsupported studies were used to obtain Food and Drug Administration (FDA) approval for naltrexone, the first medication approved for alcohol dependence in more than 40 years. These studies also changed the land scape of the NIAAA medications devel opment program. (Johnson 2009; Johnson et al. 2006) . Studies also are ongoing to evaluate medication efficacy in various undertreated populations, including people with comorbid psychiatric, substance abuse, and/or medical conditions; adolescents; and young adults. Because no current alcohol medication is effective for everyone, new efforts are underway to predict the patients who are likely to respond positively and those who are likely to experience adverse events. This progress toward person alized medicine is exemplified by the findings that the A118G allele on the opioid receptor gene is associated with a positive response to naltrexone (Oslin et al. 2003) and that the L versus S allele of the serotonin transporter gene appears to influence alcohol craving and response to ondansetron (AitDaoud et al. 2009; Johnson 2009 Results of these initiatives during the next decade should lead to improved treatment outcomes, thereby sparing affected individuals and their families costly alcoholismassociated medical, psychological, social, economic, and personal problems. (For more infor mation on the use of medications and other treatment methods for alcohol use disorders, see the article on pp. 55 of this issue.)
Collaborating Across the National Institutes of Health and Beyond
To achieve the research and public health successes described here and to meet the current and future challenges that lie ahead, NIAAA recognizes the importance of working with scientists and administrators outside its own agency and has strived to establish connections and collaborations across the National Institutes of Health (NIH) and around the world.
NIAAA and Global Health
NIAAA has had a strong global presence throughout much of its 40year history. Because the problems that arise from harmful use of alcohol pose considerable challenges for societies throughout the world, the international alcohol research community has recognized the need for scientific collaboration to accelerate knowledge building in this area to improve public health. NIAAA develops and supports collaborations with foreign scientists that range from molecular and cellular studies of alcohol's impact on liver and brain function to studies of effective identification and treatment of children with FASD. And NIAAA's role in international scientific collabo rations is increasing in importance: alcohol misuse has recently been identi fied as a significant global health priority by the health community at large (Lancet, Vol. 373, June 27, 2009) , and the WHO is scheduled to put a sub stantial focus on this health issue with the adoption of its "Global Strategy to Reduce Harmful Use of Alcohol" at the May 2010 World Health Assembly.
Historically, support for international alcohol scientific projects has comprised 1 to 2 percent of NIAAA's annual extramural research budget. But this small investment has led to important scientific findings. For example, col laboration between investigators in Canada and the Indiana University Alcohol Research Center revealed that rats selectively bred to like alcohol dis play a higher preference for nicotine, providing a basis to study genetic influences in human patterns of alcohol and nicotine addiction (Le et al. 2006 ). In another collaborative study, scien tists at SCRIPPS Alcohol Research Center and investigators in Trinidad found an important interaction between genetic and environmental risk fac tors that influences the development of alcohol dependence and alcohol related liver disease in AfroTrinidadians that also influences alcohol use in African Americans who have the same gene sequence (Ehlers et al. 2007) .
Understanding the role of alcohol abuse and dependence in the devel opment of human immunodeficiency virus (HIV)/AIDS has increased tremendously as a result of international collaboration between NIAAAfunded scientists in the United States and investigators in Africa, India, and Russia. International alcohol research groups have had significant involve ment in NIAAA cross disciplinary ini tiatives, such as the French Institut National de la Santé et de la Recherche Médicale (INSERM)supported laboratory that participates in the Integrative Neuroscience Initiative on Alcoholism (INIA), and the contribu tions of investigators from South Africa, Finland, Italy, Ukraine, Australia, Northern Ireland, and Russia to the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD).
The NIAAA intramural program also has strategically invested in inter national collaborative research on alcohol through the training of hun dreds of foreign research fellows over the years who not only contribute to research in NIAAA's intramural research programs while in the United States but who continue to collaborate with U.S. colleagues on scientific projects upon return to their home countries. In addition, NIAAA intramural research scientists conduct important studies overseas. For example, a cur rent effort led by NIAAA's Biometry and Epidemiology Branch is looking at alcohol use in hospital emergency department patients at several sites in China, Taiwan, Korea, and Japan in a collaborative effort to determine the association between alcohol use and injury as a first step toward develop ing effective prevention interventions.
TransNIH Collaborations
Other research partnerships have tran spired closer to home. NIAAA has participated in several transNIH initiatives including the following:
• The NIH Obesity Research Task Force, to accelerate progress in obesity research and education across NIH.
• The NIH Blueprint for Neuroscience Research, a cooperative effort that pools resources and expertise to sup port the development of new tools, training opportunities, and other resources to assist neuroscientists in both basic and clinical research. (For more information on NIAAA's role in neuroscience research, see the article on p. 127 of this issue.)
• The NIH Pain Consortium, which promotes collaboration among researchers studying sensory and basic mechanisms of pain as well as the emotional and biobehavioral aspects of pain.
• The NIH Public Trust Initiative (PTI), which is working to promote public understanding and confidence in the research that NIH conducts and supports across the country and throughout the world.
NIAAA and the NIH Common Fund.
The NIH Common Fund is a collec tion of farreaching initiatives designed to transform the Nation's medical research capabilities and improve the translation of research into practice. NIAAA is actively participating in the Metabolomics Technology Development Initiative; the Genes, Environment, and Health Initiative to understand the interaction between genes and the environment and the impact on health and disease; and the Roadmap Epigenomics Program, all of which emerged from NIH Common Fund initiatives.
Outreach and Dissemination of Research Findings
Research findings about the best ways to prevent and treat alcohol problems can have a significant impact on public health but only if those findings are adequately reported and translated to the relevant audiences. An important part of NIAAA's mission, therefore, is "translating and disseminating research findings to health care providers, researchers, policymakers, and the public." NIAAA's pioneering work in public outreach, communications, and clinician training aims to stimulate new areas of research and foster growth in the field; to improve prevention efforts and treatment outcomes; and to edu cate the general public about alcohol and alcoholism. Through its award winning publications, Web sites, elearning tools, and public service announcements, NIAAA targets a variety of audiences. of drinking while taking common prescription and overthecounter medications. A revised version of this publication has been adapted for an older audience-the population most likely to be taking prescription medications.
Materials and Audiences
In and HBO, NIAAA helped to produce HBO's The Addiction Project. The Project included a 14part documentary that aired on HBO main service, mul tiplex channels, HBOOnDemand, podcasts, Web streams, and DVD.
In recent years, NIAAA has embraced new technology to further its mission. NIAAA has produced an "elearning" educational program for health care professionals based on the Clinician's Guide. This interactive, Webbased course offers four 10 minute video cases based on scenarios clinicians might face in everyday practice and provides evidencebased clinical strategies for dealing with patients at different levels of severity and readiness to change. Physicians and nurses who complete the course can earn continuing medical educa tion (CME) or continuing education (CE) credits through Medscape ® ; in the first 3 weeks the program was offered, 3,600 participants earned credit.
Evidence of Success
NIAAA is succeeding in fulfilling its mandate to bring information to researchers, clinicians, and the general public. NIAAA's publications are widely distributed, and its work often is publicized extensively in the news media. Outreach efforts also have won multiple awards, and clinicians and professional and government organiza tions are adopting NIAAA's evidence based practices.
The Clinician's Guide has been included in the clinical practice guide lines of several HMOs. Since its launch, NIAAA's College Drinking Task Force Web site has had more than 114 mil lion visitors. In addition, statistics from the Task Force materials are commonly cited in both research papers and public policy to describe the extent of the problem. 
Future Directions
Looking to the future, NIAAA has selected Alcohol Research & Health and Alert topics that will focus on the latest findings from the alcohol research field, striking a unique balance between biomedical and psychosocial topics. Upcoming publications will address, in particular, the problem of health disparities and will target populations who are especially at risk for alcohol related problems. (For more informa tion on NIAAA's role in health dispari ties and alcohol research, see the article on p. 152 of this issue.) NIAAA will translate more publications, including Rethinking Drinking, into Spanish. Additionally, NIAAA currently is devel oping a curriculum for undergraduate nursing faculty with topics such as the neurobiology of addictions; screening, treatment, and prevention issues; and management of intoxication and with drawal that will help educate a new generation of nurses on issues related to alcohol research.
Looking Forward
As NIAAA moves into its 40th year as the Nation's lead agency on alcohol abuse and alcoholism research, it looks back on a rich and productive invest ment in research on a wide range of areas, including genetics, neuroscience, epidemiology, health risks and benefits of alcohol consumption, prevention, and treatment. As technological advances continue, such as novel highthrough put technology and complete annota tion of the mouse genome, the field is set to move into a new era of discovery for alcohol research. In the area of treatment for alcoholism, the emerging field of personalized medicine promises to apply information about a patient's protein, gene, or metabolite profile to tailor treatment to that individual's needs. NIAAA also is pursuing the challenge of preventing and treating alcohol problems among special popu lations to decrease health disparities and further improve public health. To attain success in these and other endeavors, NIAAA will continue to rely on its partnerships with individuals and agencies within NIH and around the world. ■
